Idexx Laboratories has purchased a company in Oregon that provides veterinary telemedicine services, from MRI scans to ECG screens.Westbrook-based Idexx bought VDIC, which will join Idexx's ...

WESTBROOK, Maine, February 13, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: ...

A high-level overview of IDEXX Laboratories, Inc. (IDXX) stock. View (IDXX) real-time stock price, chart, news, analysis, analyst reviews and more.

IDEXX outlined its 2025 revenue target of $4.055 billion to $4.170 billion, reflecting organic growth of 6% to 9%. The CAG Diagnostic recurring revenue is expected to grow between 5% and 8% ...

IDEXX is also estimated 2025 earnings per share to range from $11.74 to $12.24, representing an increase of 10% to 15% as reported and 8% to 12% on a comparable basis.

IDEXX's total sales in the quarter rose about 9% to $916 million, but missed analysts' average estimate of $926.16 million. Its quarterly profit was at $2.53 per share, compared with $2.15 per ...

Idexx's financial health is strong. The firm had historically funded its expansions and acquisitions primarily through its own cash generation and held virtually no long-term debt until 2014.